What is the risk of recurrence for patients with ICH classified using CMBs as due to CAA?
In a recent pooled analysis of observational studies, patients with ICH classified using CMBs as due to CAA had an approximately 7% annual recurrence risk, compared with about 1% for those not fulfilling criteria for CAA.